Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-07-12

Clinical Trial Update: Promotion of Coronary Collateral Function by Ivabradine-Induced Bradycardia in Patients With Coronary Artery Disease [NA]

View source ↗

Summary

A completed clinical trial investigated whether ivabradine-induced bradycardia improves coronary collateral function in patients with coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IVABRADINE

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Coronary Artery Disease | NA | Status: COMPLETED